Buccal formulations of galanthamine and uses thereof

Details for Australian Patent Application No. 2004273574 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Asmussen, Bodo; Moormann, Joachim

Agent Hodgkinson McInnes

Pub. Number AU-B-2004273574

PCT Pub. Number WO2005/027870

Priority 103 38 544.4 19.08.03 DE

Filing date 23 April 2004

Wipo publication date 31 March 2005

Acceptance publication date 13 May 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 25/32 (2006.01) Drugs for disorders of the nervous system

A61P 25/34 (2006.01) Drugs for disorders of the nervous system

Event Publications

16 March 2006 PCT application entered the National Phase

  PCT publication WO2005/027870 Priority application(s): WO2005/027870

13 May 2010 Application Accepted

  Published as AU-B-2004273574

9 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004273583-Device and method for applying active substances to the surface of a wound

2004273573-Albumin-binding derivatives of therapeutic peptides